The apparent paradox of having TFPI1 act as a tumor suppressor, yet be highly expressed in aggressive tumors was recently noted, and it was suggested that this could be explained if increased TFPI1 in more aggressive tumors provides a means to reduce the increased TF and thrombin activity in these cells, thus acting as a marker of aggressive tumors [45,46]. Here, TFPI is linked to neoplasm.